NFL has been considered as a marker of axonal damage in different neurological disorders (Herbert et al., 2015) and, in the light of some recent data (Backstrom et al., 2015), has become of potential interest as a CSF biomarker in PD. The gene discussed is NEFL; the disease is nervous system disorder.